First-Time Startup Equity Grant: Audit It Before You Accept
Treat your first startup equity grant like a new contract: audit option type, strike price, vesting, post-termination window, and size before you celebrate.
Equity is moving into roles that used to get cash only
You just got a grant with a share count, a strike price, and a vesting schedule. The trap is simple: a startup equity grant can look like a bonus and still be a thin, short-dated promise. The rule is to audit it before you accept. For a role that just started getting equity, treat the grant as a new contract, not a surprise gift.
Sales rep equity is becoming more common, and marketing stock options are no longer a rare perk for non-engineer roles. Deel's review of 8,000 grants at 480 companies found that the count of sales staff getting equity grants increased almost 30% from mid-2025, while marketing roles rose 24%. Deel saw sales roles rise from 18% to 27% of its employee-of-record equity grants since 2023. Among tech companies, Microsoft, Google, Meta, Amazon and Intel are the most likely to offer equity to staff in sales, marketing and human resources.
More than 8,000 employees across nearly 100 countries received equity through Deel in the last four years. Workers receiving stock awards rose 62% in Germany and 51% in India between the first half of 2025 and the first half of 2026, compared with 29% in the US.
The terms decide when you earn value, what you pay for it, and how long you have to use it. The audit turns the grant into dates, prices, and choices. A skipped audit can leave you celebrating a grant that is smaller, slower, or shorter than you thought.
A grant can look generous and still be thin
A share count is only one input. If the company is private, the latest 409A valuation is the best public proxy for fair market value. The strike price is the price you pay to buy each share, and it can make the grant look better or worse than it is. Ask for the valuation date, because an old valuation can make the price look lower than it is.
The option type changes the tax timing. One type can defer tax until sale if you hold the shares long enough; the other is taxed when you buy the shares, on the difference between the share value and your price. The difference can matter more than the headline grant size.
Vesting decides how long you must stay. A cliff is the first date a chunk vests, and the schedule tells you how much vests after that. The schedule is the price of staying. Leaving early can mean getting nothing. After you leave, the post-termination exercise window decides how long you have to buy shares you have already earned.
Size matters in context. A grant that is large for a late-stage company may be small for an early-stage one. A grant that is normal for a senior sales role may be small for a founder-level role. The benchmark comes from the function, the stage, and the terms. A benchmark without terms is just a number.
The audit tells you whether the grant is real
Do not accept a verbal summary. Ask for the grant agreement, the latest 409A valuation, and the plan document. When any answer is missing, pause. The documents should match the offer letter. Use this list as the minimum audit.
- Option type: Confirm whether the grant is an ISO (incentive stock option) or an NSO (nonqualified stock option).
- Strike price: Compare the strike price against the latest 409A valuation, the company's fair-market estimate.
- Vesting cliff: Confirm the first date a chunk vests and the total schedule.
- Post-termination exercise window: Confirm the time you have to buy shares you have already earned after you leave.
- Size: Compare the grant to similar roles at similar stage companies.
When the company says the terms are standard, ask for the document that says so. Keep the answers with the offer letter, and reread them before you sign.
